MHRA Drug Safety Update – July 2018

MHRA Drug Safety Update – July 2018

July 20, 2018

Date issued: 17th July 2018

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 11, Issue 12, July 2018) has been published and includes articles on:

  • pressurised metered dose inhalers (pMDI): risk of airway obstruction from
    aspiration of loose objects;
  • eltrombopag (Revolade): reports of interference with bilirubin and creatinine test
    results; and
  • medicines taken during pregnancy: please report suspected adverse drug reactions, including in the baby or child, on a Yellow Card.

To see the latest MHRA Drug Safety Update in full, visit the website.

Posted in:

More Latest News >

EPS Phase 4 piloting

NHS Digital continues to pilot EPS Phase 4. All pharmacy staff need to be aware that they could receive a...

PSNC Job Opportunity: Office Administrator

PSNC (the Pharmaceutical Services Negotiating Committee) represents England’s community (high-street) pharmacies, and is looking to recruit an Office Administrator to...